FdaApplication
NDA 215457
Identifiers
- fda_app_no: NDA215457
Properties
| Property | Value |
|---|---|
| applicant_name | KALEO INC |
| application_type | NDA |
| approval_date | 2022-02-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NALOXONE HYDROCHLORIDE (AUTOINJECTOR) | NALOXONE HYDROCHLORIDE | 10MG/0.4ML (10MG/0.4ML) | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS |
1 product